Clinical Trials in Massachusetts

Showing 3661-3680 of 15,316 trials

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

NCT05765500

This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels, cholesterol, and blood sugar. The drugs are already standard treatment for people with prostate cancer, and the drugs will be used as described in their label. The names of the study drugs involved in this study are: * Leuprolide (type of ADT) * Relugolix (type of ADT)

Prostate CancerProstatic Neoplasms

Dana-Farber Cancer Institute110 participantsStarted Feb 2024

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Foxborough, Massachusetts, United States

Active Not RecruitingNA26 miles

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Ischemic StrokeSystemic Embolism

AtriCure, Inc.6,573 participantsStarted Jan 2023

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +140 more locations

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Find Trials by Condition in Massachusetts

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

Decisions About Cancer Screening in Alzheimer's Disease

The Women's Health Study: From Adolescence to Adulthood

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors